Published in Exp Hematol on December 01, 1993
Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia (2009) 2.11
Hepatitis B vaccination of babies in Melanesia. Lancet (1995) 2.07
Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum (1987) 1.70
Transfusion guidelines for neonates and older children. Br J Haematol (2004) 1.61
The international reference preparation of erythropoietin. Bull World Health Organ (1966) 1.60
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med (2012) 1.60
Modes of hepatitis B virus transmission in New Zealand. N Z Med J (1989) 1.39
ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr (2006) 1.37
Clinical features, diagnosis and outcome of acute portal vein thrombosis. QJM (2000) 1.37
Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations. Gut (1991) 1.31
Efficient production of hepatitis B surface antigen using a bovine papilloma virus-metallothionein vector. J Mol Appl Genet (1984) 1.21
Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods (1987) 1.21
Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol (1982) 1.19
Effects of peptides from the calcitonin genes on bone and bone cells. Q J Exp Physiol (1988) 1.14
Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum (1986) 1.11
The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods (1998) 1.10
Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase. J Biol Chem (1994) 1.10
Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care (1999) 1.07
Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis. J Med Genet (2007) 1.06
Development of the immune response in the foetal and newborn rhesus monkey. I. Response to bovine serum albumin. Immunology (1966) 1.05
Collaborative study of estimates by radioimmunoassay of insulin concentrations in plasma samples examined in groups of five or six laboratories. J Endocrinol (1969) 1.03
Antibody-producing capacity in human cancer. Br J Cancer (1970) 1.00
Platelet transfusions in haematology patients: are we using them appropriately? Vox Sang (2012) 1.00
Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol (1985) (1985) 0.99
Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties. Br J Haematol (1998) 0.97
Cost-benefit analysis of the use of TBT: the case for a treatment approach. Sci Total Environ (2000) 0.97
Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity. Arch Dis Child (1993) 0.96
Successful ageing in adversity: the LASER-AD longitudinal study. J Neurol Neurosurg Psychiatry (2007) 0.96
Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findings. N Z Med J (1995) 0.95
The international standards for interleukin-1 alpha and interleukin-1 beta. Evaluation in an international collaborative study. J Immunol Methods (1991) 0.94
Possible X linked congenital mitochondrial cardiomyopathy in three families. J Med Genet (1993) 0.93
Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. Prog Liver Dis (1992) 0.93
Subcutaneous erythropoietin and peritoneal dialysis. Lancet (1989) 0.93
A Bayesian method for single molecule, fluorescence burst analysis. Biomed Opt Express (2010) 0.93
Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia. Clin Sci (Lond) (1985) 0.92
Measurement of antibody-producing capacity in man. 3. The response to flagellin from Salmonella adelaide in chronic diseases. Int Arch Allergy Appl Immunol (1971) 0.91
Prevalence of hepatitis B infections in a multiracial New Zealand community. N Z Med J (1985) 0.91
Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol (2001) 0.90
SCAN, an exploratory program for preliminary analysis of bioassay and immunoassay data. Comput Methods Programs Biomed (1985) 0.90
The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease. Xenobiotica (2010) 0.89
Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia. Gastroenterology (1984) 0.89
Changes in serum immunoreactive erythropoietin during the menstrual cycle and normal pregnancy. Br J Obstet Gynaecol (1983) 0.88
Definition and measurement of follicle stimulating hormone. Endocr Rev (2000) 0.88
A direct action of human calcitonin gene-related peptide on isolated osteoclasts. J Endocrinol (1987) 0.88
Effect of mixing technique on the properties of acrylic bone-cement: a comparison of syringe and bowl mixing systems. J Arthroplasty (2000) 0.87
The second international reference preparation of erythropoietin, human, urinary, for bioassay. Bull World Health Organ (1972) 0.87
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles. J Med Chem (1999) 0.87
The First International Standard for Antitetanus Immunoglobulin, Human; pharmaceutical evaluation and international collaborative study. Biologicals (1993) 0.86
Postnatal disappearance of the pregnancy-associated reduced sensitivity of plasma cortisol to feedback inhibition. Life Sci (1987) 0.85
Antenatal fetal heart rate variation in relation to the respiratory and metabolic status of the compromised human fetus. Br J Obstet Gynaecol (1988) 0.85
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication. Psychol Med (1978) 0.85
Use of a common standard for comparison of insulin C-peptide measurements by different laboratories. Diabetologia (1980) 0.85
Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase. Xenobiotica (2006) 0.84
Gonadotropin secretion abnormalities in chronic schizophrenia. Psychol Med (1982) 0.84
Diurnal variation of serum immunomoreactive erythropoietin in a normal subject. Clin Endocrinol (Oxf) (1982) 0.84
Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. N Engl J Med (1986) 0.84
Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. Br J Haematol (2005) 0.84
Long-term survival and quality of life in patients treated with a national all protocol 15-20 years earlier: IDM/HDM and late effects? Pediatr Hematol Oncol (1997) 0.84
The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care (1996) 0.84
Hepatitis B carriage in children. N Z Med J (1983) 0.83
The fourth International Standard for Human Urinary FSH and LH: specificities of LH seminal vesicle weight gain assays in the collaborative study differ between laboratories. J Endocrinol (2001) 0.83
3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. J Med Chem (1994) 0.83
Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor. J Med Chem (1999) 0.82
Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology (1992) 0.82
Vitamin D deficiency rickets and vitamin B12 deficiency in vegetarian children. Acta Paediatr Scand (1985) 0.82
Weight-bearing parallel-beam scanography for the measurement of leg length and joint alignment. J Bone Joint Surg Br (1994) 0.82
Latent autoimmune diabetes in adults (LADA)--more than a name. Diabetologia (2006) 0.82
Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years. J Infect Dis (1992) 0.81
Antibodies to type II collagen in human serum: storage effects and role of IgM antiidiotype in regulation. J Rheumatol (1994) 0.81
Very-low-dose hepatitis B vaccine in newborn infants: an economic option for control in endemic areas. Lancet (1987) 0.81
Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores. Br J Haematol (1992) 0.81
Nocturnal desaturation and serum erythropoietin: a study in patients with chronic obstructive pulmonary disease and in normal subjects. Clin Sci (Lond) (1993) 0.80
Contractions mediated by alpha 1-adrenoceptors and P2-purinoceptors in a cat colon circular muscle. Br J Pharmacol (1994) 0.80
Growth and survival of rumen fungi. Biosystems (1988) 0.80
Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia (2005) 0.80
Dimensional analysis of osteoclastic bone resorption and the measurement of biologically active calcitonin. Exp Physiol (1994) 0.80
Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment. Br J Haematol (1990) 0.80
The international reference preparation of human pituitary luteinizing hormone, for immunoassay. Acta Endocrinol (Copenh) (1978) 0.80
Erythropoietin and cord blood haemoglobin in the regulation of human fetal erythropoiesis. Br J Obstet Gynaecol (1983) 0.79
The International Standard for Human Growth Hormone for Bioassay: calibration and characterization by international collaborative study. Mol Cell Endocrinol (1985) 0.79
Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD. Contrib Nephrol (1989) 0.79
Amino acid losses in ileostomy fluid on a protein-free diet. Am J Clin Nutr (1994) 0.79
Severe gestational (incidental) thrombocytopenia: to treat or not to treat. Hematology (2005) 0.79
Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia. Bone Marrow Transplant (1991) 0.79
Intramuscular versus intradermal hepatitis B vaccination. N Z Med J (1986) 0.79
An immunological cross-reactant of erythropoietin in serum which may invalidate EPO radioimmunoassay. Br J Haematol (1989) 0.79
Detection of endotoxin in mice by measurement of endotoxin-induced changes in plasma concentrations of zinc and of the acute-phase protein serum amyloid P-component. J Pharm Pharmacol (1986) 0.79
Experimental tests of prospective remembering: the influence of cue-event frequency on performance. Br J Psychol (1999) 0.79
Inhibition of enzyme function by human autoantibodies to an autoantigen pyruvate dehydrogenase E2: different epitope for spontaneous human and induced rabbit autoantibodies. Clin Exp Immunol (1990) 0.79
International collaborative study of N.I.B.S.C. research standard for human parathyroid hormone for immunoassay. J Endocrinol (1980) 0.79
Phenomenal causality: impressions of pulling in the visual perception of objects in motion. Am J Psychol (1997) 0.79
Comparison of augmentation of human natural killer cell cytotoxicity by interferon-alpha subtypes. Nat Immun Cell Growth Regul (1990) 0.78
Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. Br J Haematol (1992) 0.78
Role of paediatric intensive care following adenotonsillectomy for severe obstructive sleep apnoea: criteria for elective admission. J Laryngol Otol (2012) 0.78
Guidelines for the specification, implementation and management of information technology systems in hospital transfusion laboratories. Transfus Med (2014) 0.78
Establishing a postgraduate qualification in remote health care. J Telemed Telecare (1996) 0.78